<DOC>
	<DOCNO>NCT02514226</DOCNO>
	<brief_summary>Background : Association periodontal disease ( PD ) chronic obstructive pulmonary disease ( COPD ) widely study aspiration periodontal pathogens one accept causal mechanism pulmonary exacerbation . Bronchiectasis clinically quite similar COPD , include chronic administration antibiotic , increase systemic inflammation relatively similar clinical symptom , time ; study correlate condition PD . This study evaluate scale root planning ( SRP ) associate photodynamic therapy improve periodontal clinical parameter , halitosis , quantity microorganism associate exacerbation bronchiectasis saliva , subgingival periodontal microenvironment , sputum nasal lavage baseline , 3 month one year SRP . Methods/Design : Ninety patient chronic periodontal disease bronchiectasis enrol study treat follow : G1 control ( n = 30 ) - supragingival scaling ( SS ) dental hygiene orientation ( DHO ) ; G2 experimental ( n = 30 ) - SRP + DHO ; G3- experimental ( n = 30 ) - SRP + PDT + DHO . The quantification bacterial group commonly associate exacerbation bronchiectasis ( P aeruginosa , S. aureus ) periodontal disease ( P. gingivalis ) , evaluate periodontal pocket , saliva , nasal lavage sputum quantitative PCR baseline 3 month one year SRP . G1 patient receive SRP upon completion investigation . If mean depth probe group worsen ( &gt; 1mm ) 3 month exclude study , treat ( SRP ) data described . Discussion : The result protocol determine efficacy periodontal treatment decrease total amount microorganism saliva periodontal pocket , sputum nasal lavage , probable niche bronchiectasis exacerbation , reduce local inflammation halitosis 3 month one year . It expect higher improvement parameter measure 3 month 1 year G3</brief_summary>
	<brief_title>Evaluation Periodontal Treatment Patients With Bronchiectasis</brief_title>
	<detailed_description />
	<mesh_term>Bronchiectasis</mesh_term>
	<mesh_term>Periodontal Diseases</mesh_term>
	<mesh_term>Gingival Diseases</mesh_term>
	<mesh_term>Methylene Blue</mesh_term>
	<criteria>Patients must &gt; 35 year , gender , &gt; 10 teeth chronic moderate generalize periodontal disease , i.e . 30 % teeth examine â‰¥ 4 mm probe depth . Exclusion criterion include smoker former smoker less five year , pregnant , people cystic fibrosis asthma , phenytoin cyclosporine user ( affect periodontal status ) , decompensated systemic disease require prophylactic antibiotic therapy periodontal treatment , use oral antiseptic antiinflammatory last 3 month , periodontal treatment perform last 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>microbiology</keyword>
	<keyword>halitosis</keyword>
</DOC>